@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://www.w3.org/ns/prov#> .
@prefix this: <http://purl.org/np/RARwLweDfjednyeWRhvfxhQxf_nFIK-MVtinCWcbezwYU> .
@prefix sub: <http://purl.org/np/RARwLweDfjednyeWRhvfxhQxf_nFIK-MVtinCWcbezwYU#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix nkg: <https://w3id.org/um/neurodkg/> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_2951> bl:category bl:Disease .
  
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_2951>;
    rdf:predicate bl:treats;
    rdf:subject <https://identifiers.org/drugbank:DB00747>;
    a rdf:Statement;
    rdfs:label "scopolamine transdermal system is an anticholinergic agent indicated in adults for the prevention of nausea and vomiting associated with scopolamine transdermal system is indicated in adults for prevention of nausea and vomiting associated with motion sickness see clinical studies 14 1 scopolamine transdermal system is indicated in adults for prevention of nausea and vomiting associated with recovery from anesthesia and or opiate analgesia and surgery see clinical studies 14 2";
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
    bl:provided_by <https://w3id.org/um/NeuroDKG>;
    bl:relation nkg:SymptomaticReliefIndication .
  
  <https://identifiers.org/drugbank:DB00747> bl:category bl:Drug .
}

sub:provenance {
  sub:assertion ns1:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
    npx:hasSignature "M3zObx9kOtT8eQeQZlu1gLqX7zvKMHGTjwWgvgMGao1cv0ObsZm39c89Z7mK9an9Nn8Cu88zmzaBSv5jNcg0AhQiIMkDlmuEouO+WUONRuXy2XFvjpw2+2gcIm1Q6FdYlP+QhDL+DFIonioUDh1MuuqxZs7Dsz3pOjKuiQULAoE=";
    npx:hasSignatureTarget this: .
  
  this: dcterms:created "2021-06-29T08:33:00.401+02:00"^^xsd:dateTime;
    dcterms:creator orcid:0000-0002-1468-3557;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> .
}